Medical Care
Rapid Antigen Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 658540
- Pages: 106
- Figures: 186
- Views: 6
The global market for Rapid Antigen Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Antigen Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Antigen Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Rapid Antigen Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Rapid Antigen Testing include Abbott Laboratories, F. Hoffmann-La Roche, Oxford BioMedica, Affinity Biologicals, Epitope Diagnostics, Sino Biological, R-Biopharma, Cell Biolabs and Thermo Fisher Scientific, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapid Antigen Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rapid Antigen Testing by region & country, by Type, and by Application.
The Rapid Antigen Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antigen Testing.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Segment by Type:
Immunosorbent Assay
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rapid Antigen Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rapid Antigen Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rapid Antigen Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Rapid Antigen Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Antigen Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Rapid Antigen Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Rapid Antigen Testing include Abbott Laboratories, F. Hoffmann-La Roche, Oxford BioMedica, Affinity Biologicals, Epitope Diagnostics, Sino Biological, R-Biopharma, Cell Biolabs and Thermo Fisher Scientific, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapid Antigen Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rapid Antigen Testing by region & country, by Type, and by Application.
The Rapid Antigen Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antigen Testing.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Segment by Type:
Immunosorbent Assay
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rapid Antigen Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rapid Antigen Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rapid Antigen Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Rapid Antigen Testing Product Introduction
1.2 Global Rapid Antigen Testing Market Size Forecast
1.3 Rapid Antigen Testing Market Trends & Drivers
1.3.1 Rapid Antigen Testing Industry Trends
1.3.2 Rapid Antigen Testing Market Drivers & Opportunity
1.3.3 Rapid Antigen Testing Market Challenges
1.3.4 Rapid Antigen Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rapid Antigen Testing Players Revenue Ranking (2023)
2.2 Global Rapid Antigen Testing Revenue by Company (2019-2024)
2.3 Key Companies Rapid Antigen Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rapid Antigen Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Rapid Antigen Testing
2.6 Rapid Antigen Testing Market Competitive Analysis
2.6.1 Rapid Antigen Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rapid Antigen Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunosorbent Assay
3.1.2 Enzyme-linked Immunosorbent
3.1.3 Precipitation Reaction
3.1.4 Radioimmunoassay
3.1.5 Agglutination Reaction
3.1.6 Complement Fixatio
3.2 Global Rapid Antigen Testing Sales Value by Type
3.2.1 Global Rapid Antigen Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rapid Antigen Testing Sales Value, by Type (2019-2030)
3.2.3 Global Rapid Antigen Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Diagnostic Centers
4.1.4 Others
4.2 Global Rapid Antigen Testing Sales Value by Application
4.2.1 Global Rapid Antigen Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rapid Antigen Testing Sales Value, by Application (2019-2030)
4.2.3 Global Rapid Antigen Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rapid Antigen Testing Sales Value by Region
5.1.1 Global Rapid Antigen Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rapid Antigen Testing Sales Value by Region (2019-2024)
5.1.3 Global Rapid Antigen Testing Sales Value by Region (2025-2030)
5.1.4 Global Rapid Antigen Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rapid Antigen Testing Sales Value, 2019-2030
5.2.2 North America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rapid Antigen Testing Sales Value, 2019-2030
5.3.2 Europe Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rapid Antigen Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rapid Antigen Testing Sales Value, 2019-2030
5.5.2 South America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rapid Antigen Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rapid Antigen Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rapid Antigen Testing Sales Value
6.3 United States
6.3.1 United States Rapid Antigen Testing Sales Value, 2019-2030
6.3.2 United States Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rapid Antigen Testing Sales Value, 2019-2030
6.4.2 Europe Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rapid Antigen Testing Sales Value, 2019-2030
6.5.2 China Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rapid Antigen Testing Sales Value, 2019-2030
6.6.2 Japan Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rapid Antigen Testing Sales Value, 2019-2030
6.7.2 South Korea Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rapid Antigen Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rapid Antigen Testing Sales Value, 2019-2030
6.9.2 India Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Rapid Antigen Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Profile
7.2.2 F. Hoffmann-La Roche Main Business
7.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Products, Services and Solutions
7.2.4 F. Hoffmann-La Roche Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Profile
7.3.2 Oxford BioMedica Main Business
7.3.3 Oxford BioMedica Rapid Antigen Testing Products, Services and Solutions
7.3.4 Oxford BioMedica Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Affinity Biologicals Recent Developments
7.4 Affinity Biologicals
7.4.1 Affinity Biologicals Profile
7.4.2 Affinity Biologicals Main Business
7.4.3 Affinity Biologicals Rapid Antigen Testing Products, Services and Solutions
7.4.4 Affinity Biologicals Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Affinity Biologicals Recent Developments
7.5 Epitope Diagnostics
7.5.1 Epitope Diagnostics Profile
7.5.2 Epitope Diagnostics Main Business
7.5.3 Epitope Diagnostics Rapid Antigen Testing Products, Services and Solutions
7.5.4 Epitope Diagnostics Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Epitope Diagnostics Recent Developments
7.6 Sino Biological
7.6.1 Sino Biological Profile
7.6.2 Sino Biological Main Business
7.6.3 Sino Biological Rapid Antigen Testing Products, Services and Solutions
7.6.4 Sino Biological Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Sino Biological Recent Developments
7.7 R-Biopharma
7.7.1 R-Biopharma Profile
7.7.2 R-Biopharma Main Business
7.7.3 R-Biopharma Rapid Antigen Testing Products, Services and Solutions
7.7.4 R-Biopharma Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.7.5 R-Biopharma Recent Developments
7.8 Cell Biolabs
7.8.1 Cell Biolabs Profile
7.8.2 Cell Biolabs Main Business
7.8.3 Cell Biolabs Rapid Antigen Testing Products, Services and Solutions
7.8.4 Cell Biolabs Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Cell Biolabs Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Rapid Antigen Testing Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Profile
7.10.2 Bio-Rad Laboratories Main Business
7.10.3 Bio-Rad Laboratories Rapid Antigen Testing Products, Services and Solutions
7.10.4 Bio-Rad Laboratories Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Bio-Rad Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Rapid Antigen Testing Industrial Chain
8.2 Rapid Antigen Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rapid Antigen Testing Sales Model
8.5.2 Sales Channel
8.5.3 Rapid Antigen Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Rapid Antigen Testing Product Introduction
1.2 Global Rapid Antigen Testing Market Size Forecast
1.3 Rapid Antigen Testing Market Trends & Drivers
1.3.1 Rapid Antigen Testing Industry Trends
1.3.2 Rapid Antigen Testing Market Drivers & Opportunity
1.3.3 Rapid Antigen Testing Market Challenges
1.3.4 Rapid Antigen Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rapid Antigen Testing Players Revenue Ranking (2023)
2.2 Global Rapid Antigen Testing Revenue by Company (2019-2024)
2.3 Key Companies Rapid Antigen Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rapid Antigen Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Rapid Antigen Testing
2.6 Rapid Antigen Testing Market Competitive Analysis
2.6.1 Rapid Antigen Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rapid Antigen Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunosorbent Assay
3.1.2 Enzyme-linked Immunosorbent
3.1.3 Precipitation Reaction
3.1.4 Radioimmunoassay
3.1.5 Agglutination Reaction
3.1.6 Complement Fixatio
3.2 Global Rapid Antigen Testing Sales Value by Type
3.2.1 Global Rapid Antigen Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rapid Antigen Testing Sales Value, by Type (2019-2030)
3.2.3 Global Rapid Antigen Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Diagnostic Centers
4.1.4 Others
4.2 Global Rapid Antigen Testing Sales Value by Application
4.2.1 Global Rapid Antigen Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rapid Antigen Testing Sales Value, by Application (2019-2030)
4.2.3 Global Rapid Antigen Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rapid Antigen Testing Sales Value by Region
5.1.1 Global Rapid Antigen Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rapid Antigen Testing Sales Value by Region (2019-2024)
5.1.3 Global Rapid Antigen Testing Sales Value by Region (2025-2030)
5.1.4 Global Rapid Antigen Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rapid Antigen Testing Sales Value, 2019-2030
5.2.2 North America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rapid Antigen Testing Sales Value, 2019-2030
5.3.2 Europe Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rapid Antigen Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rapid Antigen Testing Sales Value, 2019-2030
5.5.2 South America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rapid Antigen Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rapid Antigen Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rapid Antigen Testing Sales Value
6.3 United States
6.3.1 United States Rapid Antigen Testing Sales Value, 2019-2030
6.3.2 United States Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rapid Antigen Testing Sales Value, 2019-2030
6.4.2 Europe Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rapid Antigen Testing Sales Value, 2019-2030
6.5.2 China Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rapid Antigen Testing Sales Value, 2019-2030
6.6.2 Japan Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rapid Antigen Testing Sales Value, 2019-2030
6.7.2 South Korea Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rapid Antigen Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rapid Antigen Testing Sales Value, 2019-2030
6.9.2 India Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rapid Antigen Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Rapid Antigen Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Profile
7.2.2 F. Hoffmann-La Roche Main Business
7.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Products, Services and Solutions
7.2.4 F. Hoffmann-La Roche Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Profile
7.3.2 Oxford BioMedica Main Business
7.3.3 Oxford BioMedica Rapid Antigen Testing Products, Services and Solutions
7.3.4 Oxford BioMedica Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Affinity Biologicals Recent Developments
7.4 Affinity Biologicals
7.4.1 Affinity Biologicals Profile
7.4.2 Affinity Biologicals Main Business
7.4.3 Affinity Biologicals Rapid Antigen Testing Products, Services and Solutions
7.4.4 Affinity Biologicals Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Affinity Biologicals Recent Developments
7.5 Epitope Diagnostics
7.5.1 Epitope Diagnostics Profile
7.5.2 Epitope Diagnostics Main Business
7.5.3 Epitope Diagnostics Rapid Antigen Testing Products, Services and Solutions
7.5.4 Epitope Diagnostics Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Epitope Diagnostics Recent Developments
7.6 Sino Biological
7.6.1 Sino Biological Profile
7.6.2 Sino Biological Main Business
7.6.3 Sino Biological Rapid Antigen Testing Products, Services and Solutions
7.6.4 Sino Biological Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Sino Biological Recent Developments
7.7 R-Biopharma
7.7.1 R-Biopharma Profile
7.7.2 R-Biopharma Main Business
7.7.3 R-Biopharma Rapid Antigen Testing Products, Services and Solutions
7.7.4 R-Biopharma Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.7.5 R-Biopharma Recent Developments
7.8 Cell Biolabs
7.8.1 Cell Biolabs Profile
7.8.2 Cell Biolabs Main Business
7.8.3 Cell Biolabs Rapid Antigen Testing Products, Services and Solutions
7.8.4 Cell Biolabs Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Cell Biolabs Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Rapid Antigen Testing Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Profile
7.10.2 Bio-Rad Laboratories Main Business
7.10.3 Bio-Rad Laboratories Rapid Antigen Testing Products, Services and Solutions
7.10.4 Bio-Rad Laboratories Rapid Antigen Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Bio-Rad Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Rapid Antigen Testing Industrial Chain
8.2 Rapid Antigen Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rapid Antigen Testing Sales Model
8.5.2 Sales Channel
8.5.3 Rapid Antigen Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Rapid Antigen Testing Market Trends
Table 2. Rapid Antigen Testing Market Drivers & Opportunity
Table 3. Rapid Antigen Testing Market Challenges
Table 4. Rapid Antigen Testing Market Restraints
Table 5. Global Rapid Antigen Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Rapid Antigen Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Rapid Antigen Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Rapid Antigen Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Rapid Antigen Testing
Table 10. Global Rapid Antigen Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Rapid Antigen Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Rapid Antigen Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Rapid Antigen Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Rapid Antigen Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Rapid Antigen Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Rapid Antigen Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Rapid Antigen Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Rapid Antigen Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Rapid Antigen Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Rapid Antigen Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Rapid Antigen Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Rapid Antigen Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Rapid Antigen Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Rapid Antigen Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Rapid Antigen Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Rapid Antigen Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Rapid Antigen Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Rapid Antigen Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories Rapid Antigen Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Rapid Antigen Testing Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. F. Hoffmann-La Roche Basic Information List
Table 37. F. Hoffmann-La Roche Description and Business Overview
Table 38. F. Hoffmann-La Roche Rapid Antigen Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Rapid Antigen Testing Business of F. Hoffmann-La Roche (2019-2024)
Table 40. F. Hoffmann-La Roche Recent Developments
Table 41. Oxford BioMedica Basic Information List
Table 42. Oxford BioMedica Description and Business Overview
Table 43. Oxford BioMedica Rapid Antigen Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Rapid Antigen Testing Business of Oxford BioMedica (2019-2024)
Table 45. Oxford BioMedica Recent Developments
Table 46. Affinity Biologicals Basic Information List
Table 47. Affinity Biologicals Description and Business Overview
Table 48. Affinity Biologicals Rapid Antigen Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Rapid Antigen Testing Business of Affinity Biologicals (2019-2024)
Table 50. Affinity Biologicals Recent Developments
Table 51. Epitope Diagnostics Basic Information List
Table 52. Epitope Diagnostics Description and Business Overview
Table 53. Epitope Diagnostics Rapid Antigen Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Rapid Antigen Testing Business of Epitope Diagnostics (2019-2024)
Table 55. Epitope Diagnostics Recent Developments
Table 56. Sino Biological Basic Information List
Table 57. Sino Biological Description and Business Overview
Table 58. Sino Biological Rapid Antigen Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Rapid Antigen Testing Business of Sino Biological (2019-2024)
Table 60. Sino Biological Recent Developments
Table 61. R-Biopharma Basic Information List
Table 62. R-Biopharma Description and Business Overview
Table 63. R-Biopharma Rapid Antigen Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Rapid Antigen Testing Business of R-Biopharma (2019-2024)
Table 65. R-Biopharma Recent Developments
Table 66. Cell Biolabs Basic Information List
Table 67. Cell Biolabs Description and Business Overview
Table 68. Cell Biolabs Rapid Antigen Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Rapid Antigen Testing Business of Cell Biolabs (2019-2024)
Table 70. Cell Biolabs Recent Developments
Table 71. Thermo Fisher Scientific Basic Information List
Table 72. Thermo Fisher Scientific Description and Business Overview
Table 73. Thermo Fisher Scientific Rapid Antigen Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Rapid Antigen Testing Business of Thermo Fisher Scientific (2019-2024)
Table 75. Thermo Fisher Scientific Recent Developments
Table 76. Bio-Rad Laboratories Basic Information List
Table 77. Bio-Rad Laboratories Description and Business Overview
Table 78. Bio-Rad Laboratories Rapid Antigen Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Rapid Antigen Testing Business of Bio-Rad Laboratories (2019-2024)
Table 80. Bio-Rad Laboratories Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Rapid Antigen Testing Downstream Customers
Table 84. Rapid Antigen Testing Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Rapid Antigen Testing Product Picture
Figure 2. Global Rapid Antigen Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Rapid Antigen Testing Report Years Considered
Figure 5. Global Rapid Antigen Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rapid Antigen Testing Revenue in 2023
Figure 7. Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immunosorbent Assay Picture
Figure 9. Enzyme-linked Immunosorbent Picture
Figure 10. Precipitation Reaction Picture
Figure 11. Radioimmunoassay Picture
Figure 12. Agglutination Reaction Picture
Figure 13. Complement Fixatio Picture
Figure 14. Global Rapid Antigen Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Rapid Antigen Testing Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Specialty Clinics
Figure 18. Product Picture of Diagnostic Centers
Figure 19. Product Picture of Others
Figure 20. Global Rapid Antigen Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Rapid Antigen Testing Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Rapid Antigen Testing Sales Value (%), (2019-2030)
Figure 33. United States Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. China Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. China Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. India Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 53. India Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 54. Rapid Antigen Testing Industrial Chain
Figure 55. Rapid Antigen Testing Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Table 1. Rapid Antigen Testing Market Trends
Table 2. Rapid Antigen Testing Market Drivers & Opportunity
Table 3. Rapid Antigen Testing Market Challenges
Table 4. Rapid Antigen Testing Market Restraints
Table 5. Global Rapid Antigen Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Rapid Antigen Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Rapid Antigen Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Rapid Antigen Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Rapid Antigen Testing
Table 10. Global Rapid Antigen Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Rapid Antigen Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Rapid Antigen Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Rapid Antigen Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Rapid Antigen Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Rapid Antigen Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Rapid Antigen Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Rapid Antigen Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Rapid Antigen Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Rapid Antigen Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Rapid Antigen Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Rapid Antigen Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Rapid Antigen Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Rapid Antigen Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Rapid Antigen Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Rapid Antigen Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Rapid Antigen Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Rapid Antigen Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Rapid Antigen Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories Rapid Antigen Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Rapid Antigen Testing Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. F. Hoffmann-La Roche Basic Information List
Table 37. F. Hoffmann-La Roche Description and Business Overview
Table 38. F. Hoffmann-La Roche Rapid Antigen Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Rapid Antigen Testing Business of F. Hoffmann-La Roche (2019-2024)
Table 40. F. Hoffmann-La Roche Recent Developments
Table 41. Oxford BioMedica Basic Information List
Table 42. Oxford BioMedica Description and Business Overview
Table 43. Oxford BioMedica Rapid Antigen Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Rapid Antigen Testing Business of Oxford BioMedica (2019-2024)
Table 45. Oxford BioMedica Recent Developments
Table 46. Affinity Biologicals Basic Information List
Table 47. Affinity Biologicals Description and Business Overview
Table 48. Affinity Biologicals Rapid Antigen Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Rapid Antigen Testing Business of Affinity Biologicals (2019-2024)
Table 50. Affinity Biologicals Recent Developments
Table 51. Epitope Diagnostics Basic Information List
Table 52. Epitope Diagnostics Description and Business Overview
Table 53. Epitope Diagnostics Rapid Antigen Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Rapid Antigen Testing Business of Epitope Diagnostics (2019-2024)
Table 55. Epitope Diagnostics Recent Developments
Table 56. Sino Biological Basic Information List
Table 57. Sino Biological Description and Business Overview
Table 58. Sino Biological Rapid Antigen Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Rapid Antigen Testing Business of Sino Biological (2019-2024)
Table 60. Sino Biological Recent Developments
Table 61. R-Biopharma Basic Information List
Table 62. R-Biopharma Description and Business Overview
Table 63. R-Biopharma Rapid Antigen Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Rapid Antigen Testing Business of R-Biopharma (2019-2024)
Table 65. R-Biopharma Recent Developments
Table 66. Cell Biolabs Basic Information List
Table 67. Cell Biolabs Description and Business Overview
Table 68. Cell Biolabs Rapid Antigen Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Rapid Antigen Testing Business of Cell Biolabs (2019-2024)
Table 70. Cell Biolabs Recent Developments
Table 71. Thermo Fisher Scientific Basic Information List
Table 72. Thermo Fisher Scientific Description and Business Overview
Table 73. Thermo Fisher Scientific Rapid Antigen Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Rapid Antigen Testing Business of Thermo Fisher Scientific (2019-2024)
Table 75. Thermo Fisher Scientific Recent Developments
Table 76. Bio-Rad Laboratories Basic Information List
Table 77. Bio-Rad Laboratories Description and Business Overview
Table 78. Bio-Rad Laboratories Rapid Antigen Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Rapid Antigen Testing Business of Bio-Rad Laboratories (2019-2024)
Table 80. Bio-Rad Laboratories Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Rapid Antigen Testing Downstream Customers
Table 84. Rapid Antigen Testing Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Rapid Antigen Testing Product Picture
Figure 2. Global Rapid Antigen Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Rapid Antigen Testing Report Years Considered
Figure 5. Global Rapid Antigen Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rapid Antigen Testing Revenue in 2023
Figure 7. Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immunosorbent Assay Picture
Figure 9. Enzyme-linked Immunosorbent Picture
Figure 10. Precipitation Reaction Picture
Figure 11. Radioimmunoassay Picture
Figure 12. Agglutination Reaction Picture
Figure 13. Complement Fixatio Picture
Figure 14. Global Rapid Antigen Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Rapid Antigen Testing Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Specialty Clinics
Figure 18. Product Picture of Diagnostic Centers
Figure 19. Product Picture of Others
Figure 20. Global Rapid Antigen Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Rapid Antigen Testing Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Rapid Antigen Testing Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Rapid Antigen Testing Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Rapid Antigen Testing Sales Value (%), (2019-2030)
Figure 33. United States Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. China Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. China Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. India Rapid Antigen Testing Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Rapid Antigen Testing Sales Value by Type (%), 2023 VS 2030
Figure 53. India Rapid Antigen Testing Sales Value by Application (%), 2023 VS 2030
Figure 54. Rapid Antigen Testing Industrial Chain
Figure 55. Rapid Antigen Testing Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232